A Randomized, Double-Blind, Parallel, Placebo or Amlodipine-Controlled Study of the Effects of Losartan on Proteinuria in Pediatric Patients With or Without Hypertension.
Phase of Trial: Phase III
Latest Information Update: 26 Jul 2016
At a glance
- Drugs Losartan (Primary) ; Amlodipine; Enalapril
- Indications Hypertension
- Focus Pharmacodynamics
- Sponsors Merck & Co
- 05 Nov 2011 Status changed from active, no longer recruiting to completed as reported by UKCRN.
- 25 Feb 2011 Planned end date changed from 1 Feb 2011 to 1 Mar 2011 as reported by ClinicalTrials.gov.
- 13 Nov 2009 Planned end date changed from 1 Jun 2011 to 1 Feb 2011 as reported by ClinicalTrials.gov.